» Articles » PMID: 6474101

The Quality of Life Scale: an Instrument for Rating the Schizophrenic Deficit Syndrome

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 1984 Jan 1
PMID 6474101
Citations 443
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing interest in deficit symptoms in studies of the course and treatment response of schizophrenia. However, existing clinical assessment instruments focus primarily on productive symptoms. The authors describe the Quality of Life Scale (QLS), a 21-item scale based on a semistructured interview designed to assess deficit symptoms and thereby fill an important gap in the range of instruments now available. Data regarding reliability and training in the use of the QLS are presented. A factor analysis of the items yields results compatible with the conceptual model on which the scale is based. The factor analysis was also performed separately by sex and was fundamentally similar for men and women.

Citing Articles

Interpretable machine learning to evaluate relationships between DAO/DAOA (pLG72) protein data and features in clinical assessments, functional outcome, and cognitive function in schizophrenia patients.

Lin C, Lin E, Lane H Schizophrenia (Heidelb). 2025; 11(1):27.

PMID: 39987274 PMC: 11846841. DOI: 10.1038/s41537-024-00548-z.


The impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care (CSC).

Hazan H, Tayfur S, Zhou B, Li F, Gibbs-Dean T, Karmani S PLoS One. 2025; 20(2):e0312740.

PMID: 39928579 PMC: 11809850. DOI: 10.1371/journal.pone.0312740.


Avatar Intervention in Virtual Reality for Cannabis Use Disorder in Individuals With Severe Mental Disorders: Results From a 1-Year, Single-Arm Clinical Trial.

Giguere S, Beaudoin M, Dellazizzo L, Phraxayavong K, Potvin S, Dumais A JMIR Ment Health. 2024; 11:e58499.

PMID: 39602812 PMC: 11612600. DOI: 10.2196/58499.


Treatment satisfaction and effectiveness of Lurasidone on quality of life and functioning in adult patients with schizophrenia in the real-world Italian clinical practice: a prospective 3-month observational study.

De Filippis S, Vita A, Cuomo A, Amici E, Giovanetti V, Lombardozzi G Ann Gen Psychiatry. 2024; 23(1):43.

PMID: 39501351 PMC: 11536833. DOI: 10.1186/s12991-024-00531-z.


Brief ICF Core Set for Schizophrenia: Development of Criteria for Assessing the Degree of Disability.

Pinho L, Lopes M Port J Public Health. 2024; 40(1):17-25.

PMID: 39469500 PMC: 11320071. DOI: 10.1159/000524422.